BY QUINN PHILLIPS | JANUARY 1, 1970 The U.S. Food and Drug Administration (FDA) has approved a neurostimulation device from DyAnsys, Inc., to treat pain related to diabetic peripheral neuropathy, according to a press release from the company. The newly approved device, called First Relief, is what’s known as a PENS (percutaneous electrical neurostimulation) device. That means...
